Variant report

Variant	esv3327211
Chromosome Location	chr1:113798654-113801402
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 79 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:79 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs561928603	chr1:113798682-113798683	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs367887647	chr1:113798686-113798687	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs527567095	chr1:113798719-113798720	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs773612	chr1:113798723-113798724	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs570656127	chr1:113798737-113798738	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs570424083	chr1:113798778-113798779	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs532925031	chr1:113798779-113798780	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs375784061	chr1:113798831-113798832	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs188384625	chr1:113798887-113798888	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs569374327	chr1:113798900-113798901	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs538016801	chr1:113799081-113799082	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs114565163	chr1:113799087-113799088	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs115031586	chr1:113799096-113799097	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs534220896	chr1:113799128-113799129	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs537685163	chr1:113799148-113799149	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs553921554	chr1:113799164-113799165	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs17031234	chr1:113799209-113799210	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs566355059	chr1:113799319-113799320	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs545982475	chr1:113799323-113799324	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs115496206	chr1:113799335-113799336	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs576171417	chr1:113799385-113799386	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs542078950	chr1:113799397-113799398	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs76903669	chr1:113799433-113799434	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs17445086	chr1:113799512-113799513	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs74111241	chr1:113799524-113799525	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs563929749	chr1:113799526-113799527	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs377384904	chr1:113799570-113799571	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs79583074	chr1:113799571-113799572	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs536621049	chr1:113799596-113799597	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs12046651	chr1:113799598-113799599	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs554560034	chr1:113799622-113799623	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs112613371	chr1:113799632-113799633	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs111600577	chr1:113799706-113799707	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs549627069	chr1:113799742-113799743	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs113414690	chr1:113799766-113799767	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs569767698	chr1:113799778-113799779	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs528935956	chr1:113799782-113799783	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs548423476	chr1:113799783-113799784	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs568308346	chr1:113799786-113799787	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs534234902	chr1:113799788-113799789	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs548019518	chr1:113799928-113799929	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs145102904	chr1:113799929-113799930	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs570221247	chr1:113799953-113799954	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs139042147	chr1:113800031-113800032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs200259178	chr1:113800090-113800091	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs572936762	chr1:113800172-113800173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs540308509	chr1:113800174-113800175	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs71590552	chr1:113800175-113800176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs573205100	chr1:113800183-113800184	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs576637744	chr1:113800200-113800201	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Coronary Disease	20032323	CNVD
Prostate cancer	21965145	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Stargardt''s disease	17277736	CNVD
Neuroblastoma	17897457	CNVD
Uveal melanoma	21693616	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-syndromic sensorineural hearing loss	22290220	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	21264507	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	17387387	CNVD
Oligodendroglial tumors	17285580	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Neuroblastoma	17535989	CNVD
Pheochromocytoma	17535989	CNVD
Prostate cancer	16705090	CNVD
Astrocytoma	17934521	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Neuroblastoma	17533364	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Autism	22495311	CNVD
Non-small cell lung cancer	21385341	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Chordoma	21602918	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Multiple myeloma	16461302	CNVD
Cancer	21129771	CNVD
Autosomal dominant nocturnal frontal lobe epilepsy	18472482	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Thrombocytopenia-absent radius syndrome	21933853	CNVD
Psychiatric disorder	22848183	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	20409316	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17393978	CNVD
Medulloblastoma	21979893	CNVD
Cervical cancer	21062161	CNVD
Cancer	21183584	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Rett syndrome	21593744	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21720365	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Pancreatic endocrine tumor	17639061	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	17550852	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Asthma	20841430	CNVD
Aetanephric adenomas	20802469	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Systemic lupus erythematosus	21956041	CNVD
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	16573809	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Breast cancer	17899364	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Melanoma	19671679	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Bipolar disorder	19114987	CNVD
Pancreatic cancer	17952125	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:64 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:113794600-113799600	Enhancers	Fetal Intestine Small	intestine
2	chr1:113795600-113799000	Weak transcription	Sigmoid Colon	Sigmoid Colon
3	chr1:113796000-113799200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr1:113796000-113799200	Enhancers	Liver	Liver
5	chr1:113796000-113799400	Enhancers	HUES6 Cell Line	embryonic stem cell
6	chr1:113796000-113799600	Enhancers	iPS-15b Cell Line	embryonic stem cell
7	chr1:113796200-113799400	Enhancers	Stomach Mucosa	stomach
8	chr1:113796600-113799400	Enhancers	iPS-18 Cell Line	embryonic stem cell
9	chr1:113796600-113799600	Enhancers	H1 Cell Line	embryonic stem cell
10	chr1:113797000-113799600	Enhancers	Fetal Lung	lung
11	chr1:113797600-113798800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr1:113797600-113798800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr1:113797600-113798800	Enhancers	HepG2	liver
14	chr1:113797600-113799200	Enhancers	iPS-20b Cell Line	embryonic stem cell
15	chr1:113797800-113799000	Active TSS	Rectal Mucosa Donor 29	rectum
16	chr1:113797800-113799200	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr1:113798000-113799000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
18	chr1:113798000-113799000	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr1:113798000-113799000	Enhancers	Brain Germinal Matrix	brain
20	chr1:113798000-113799000	Enhancers	NHEK	skin
21	chr1:113798000-113799200	Enhancers	H9 Cell Line	embryonic stem cell
22	chr1:113798000-113799200	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr1:113798000-113799400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr1:113798200-113798800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
25	chr1:113798200-113798800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
26	chr1:113798200-113798800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
27	chr1:113798200-113799000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr1:113798200-113799600	Enhancers	Placenta	Placenta
29	chr1:113798400-113799000	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr1:113798400-113799000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr1:113798400-113799400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr1:113798400-113799400	Enhancers	Fetal Stomach	stomach
33	chr1:113798600-113798800	Enhancers	Colonic Mucosa	Colon
34	chr1:113798600-113798800	Flanking Active TSS	Duodenum Mucosa	Duodenum
35	chr1:113798600-113799000	Flanking Active TSS	Fetal Intestine Large	intestine
36	chr1:113798600-113799000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
37	chr1:113798600-113799200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr1:113798600-113799200	Enhancers	Pancreas	Pancrea
39	chr1:113798600-113799400	Enhancers	Primary T cells from cord blood	blood
40	chr1:113798600-113799400	Enhancers	Fetal Kidney	kidney
41	chr1:113798800-113799200	Enhancers	Duodenum Mucosa	Duodenum
42	chr1:113798800-113799400	Enhancers	HUES64 Cell Line	embryonic stem cell
43	chr1:113798800-113817800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
44	chr1:113799000-113799200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr1:113799000-113799200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr1:113799000-113799200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
47	chr1:113799000-113799200	Enhancers	Small Intestine	intestine
48	chr1:113799000-113799400	Enhancers	Rectal Mucosa Donor 31	rectum
49	chr1:113799000-113799400	Enhancers	Sigmoid Colon	Sigmoid Colon
50	chr1:113799000-113799400	Bivalent Enhancer	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links